# hUC-MSC-Exosomes for T2DM - Safety & Efficacy

> **NCT07693036** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 66 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **BIOLOGICAL:** exosomes treatment group
- **OTHER:** control group

## Key facts

- **NCT ID:** NCT07693036
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-05
- **Primary completion:** 2028-06-04
- **Final completion:** 2028-06-08
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07693036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07693036, "hUC-MSC-Exosomes for T2DM - Safety & Efficacy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07693036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*